OGN
Organon & CoNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$3.53B
P/E Ratio
14.44
EPS
$0.93
Beta
1.55
52W High
$13.48
52W Low
$5.68
50-Day MA
$9.71
200-Day MA
$8.72
Dividend Yield
0.60%
Profit Margin
3.99%
Forward P/E
5.09
PEG Ratio
—
About Organon & Co
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
Fundamentals
| Revenue (TTM) | $6.16B |
| Gross Profit (TTM) | $3.32B |
| EBITDA | $1.59B |
| Operating Margin | 18.70% |
| Return on Equity | 34.10% |
| Return on Assets | 5.89% |
| Revenue/Share (TTM) | $23.69 |
| Book Value | $3.44 |
| Price-to-Book | 3.91 |
| Price-to-Sales (TTM) | 0.57 |
| EV/Revenue | 1.782 |
| EV/EBITDA | 7.89 |
| Quarterly Earnings Growth (YoY) | 66.70% |
| Quarterly Revenue Growth (YoY) | -3.50% |
| Shares Outstanding | $262.60M |
| Float | $261.08M |
| % Insiders | 0.39% |
| % Institutions | 77.77% |
Historical Volatility
HV 10-Day
3.06%
HV 20-Day
55.35%
HV 30-Day
96.90%
HV 60-Day
95.01%
HV Rank
84.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.25 target)
4
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026